SOUTH SAN FRANCISCO, Calif., July 14, 2025--Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next ...

Another study linked GLP-1 receptor agonist use with higher odds of developing nonarteritic anterior ischemic optic neuropathy, a potentially blinding eye condition. Last month, the European Medicines ...

Human growth hormone (HGH) is a hormone that’s essential to our development. Most people produce enough HGH throughout their lifetime. But for those with a deficiency in growth hormone (or a few ...

[3] Effect of gonadotropin-releasing hormone agonist monotherapy and combination therapy with growth hormone on final adult height in girls with central precocious puberty. Scientific Reports (2023).

In this phase 2 trial involving persons with obesity, treatment with the 12-mg dose of retatrutide, a GIP–GLP-1–GCG receptor triple agonist, resulted in a mean weight reduction of 24.2% after ...

Contaminated hormone The work builds on the team’s previous studies of people who received cadaver-derived growth hormone, a practice that the United Kingdom stopped in 1985. In 2015, Collinge ...

The researchers wanted to better understand how hormones affect skin aging, so they focused on insulin-like growth factor-1, growth hormone, estrogen, retinoids and melatonin. Melatonin stood out ...

The U.S. Food and Drug Administration has approved Pfizer Inc and partner OPKO Health Inc's treatment for growth hormone deficiency in children, the companies said on Wednesday.

Researchers from Yuhan Corp. presented the discovery and preclinical evaluation of a novel long-acting dual agonist of the glucagon like peptide-1 (GLP-1) and growth differentiation factor 15 (GDF-15) ...